Recent Updates
Recently added Catalysts
EBS Positive Sentiment

Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025

Tuesday, July 15, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Emergent BioSolutions Inc. has announced a conference call set for August 6, 2025, to discuss its financial results for the second quarter of 2025. The call will be accessible via webcast and phone for registered participants. Interested investors can find further details on how to join the call on the company's Investors page, highlighting Emergent's dedication to keeping stakeholders informed.
Price reaction · baseline $7.3 (2025-07-14 close) · hit after-hours · clean, no other EBS news in the window
day 0 close · peak
-5.1%
day 1
-4.2%
day 3
-5.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions is actively communicating its financial results, showcasing transparency.
  • The scheduled conference call indicates ongoing engagement with investors.
  • Accessibility via webcast and telephone demonstrates commitment to shareholder communication.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+70%
120-day peak, hindsight
Typical move
8%
average across 2 past catalysts
Lead asset
FLU-IGIV
Phase 2 · Influenza A H3N2

Full Press Release Details

GAITHERSBURG, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 6, 2025, at 5:00 pm eastern time to discuss the financial results for the second quarter of 2025.
Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A replay of the call can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
Executive Vice President, CFO

Frequently Asked Questions

When is Emergent BioSolutions' Q2 2025 conference call?

The conference call is on August 6, 2025, at 5:00 pm ET.

How can participants access the conference call?

Participants can access it live via webcast or by telephone after registering.

Is there a way to replay the conference call?

Yes, a replay will be available on Emergent's Investors page.

What information is required to join the call via phone?

Participants must register in advance to receive the dial-in number and passcode.

Who can I contact for media inquiries?

Media inquiries can be sent to mediarelations@ebsi.com.

ShareAdd on Google
Tags: EBS Viatris Investor Conferences Healthcare Emergent BioSolutions Q2 2025 financial results conference call
Last updated: Jul 15, 2025

Biotech snapshot

Cash runway
$141M liquidity · $0M/mo burn
Low dilution risk
Lead asset
FLU-IGIVPhase 2
Influenza A H3N2 →

Catalyst track record

+70%
best trade around EBS's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for EBS.

See every catalyst's timing & PoA →